{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:16:41Z","timestamp":1758824201169},"reference-count":28,"publisher":"The Japanese Society for Medical Mycology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2021]]},"DOI":"10.3314\/mmj.21-00004","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T22:11:58Z","timestamp":1630361518000},"page":"53-57","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of Posaconazole against &lt;i&gt;Rhizopus oryzae&lt;\/i&gt; Infection in Silkworm"],"prefix":"10.3314","volume":"62","author":[{"given":"Sanae","family":"Kurakado","sequence":"first","affiliation":[{"name":"Department of Microbiology, Meiji Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Meiji Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sugita","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Meiji Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1842","reference":[{"key":"1","unstructured":"1) Cornely OA, Alastruey-Izquierdo A, Arenz D, et al: Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis 19: e405-e421, 2019."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kontoyiennis DP, Marr KA, Park BJ, et al: Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) database. Clin Infect Dis 50: 1091-1100, 2010.","DOI":"10.1086\/651263"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Girmenia C, Raiola AM, Piciocchi A, et al: Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Biol Blood Marrow Transplant 20: 872-880, 2014.","DOI":"10.1016\/j.bbmt.2014.02.018"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ: Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41: 634-653, 2005.","DOI":"10.1086\/432579"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Imhof A, Balajee SA, Fredricks DN, England JA, Marr KA: Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 39: 743-746, 2004.","DOI":"10.1086\/423274"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL, Diekema DJ, Pfaller MA: Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 39: 584-587, 2004.","DOI":"10.1086\/422723"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad II: Zygomycosis in a tertiary-care cancer center in the era of <i>Aspergillus<\/i>-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 191: 1350-1360, 2005.","DOI":"10.1086\/428780"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, Wingard JR, Young JA, Boeckh MJ: Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 15, 1143-1238, 2009.","DOI":"10.1016\/j.bbmt.2009.06.019"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Matsumoto Y: Facilitating drug discovery in human disease models using insects. Biol Pharm Bull 43: 216-220, 2020.","DOI":"10.1248\/bpb.b19-00834"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kaito C, Murakami K, Imai L, Furuta K: Animal infection models using non-mammals. Microbiol Immunol 64: 585-592, 2020.","DOI":"10.1111\/1348-0421.12834"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Matsumoto Y, Sekimizu K: Silkworm as an experimental animal for research on fungal infections. Microbiol Immunol 63: 41-50, 2019.","DOI":"10.1111\/1348-0421.12668"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Matsumoto Y, Sumiya E, Sugita T, Sekimizu K: An invertebrate hyperglycemic model for the identification of anti-diabetic drugs. PLoS One 6: e18292, 2011.","DOI":"10.1371\/journal.pone.0018292"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Matsumoto Y, Ishii M, Hasegawa S, Sekimizu K: <i>Enterococcus faecalis<\/i> YM0831 suppresses sucrose-induced hyperglycemia in a silkworm model and in humans. Commun Biol 2: 157, 2019.","DOI":"10.1038\/s42003-019-0407-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Hamamoto H, Horie R, Sekimizu K: Pharmacokinetics of anti-infectious reagents in silkworms. Sci Rep 9: 9451, 2019.","DOI":"10.1038\/s41598-019-46013-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kaito C, Kurokawa K, Matsumoto Y, Terao Y, Kawabata S, Hamada S, Sekimizu K: Silkworm pathogenic bacteria infection model for identification of novel virulence genes. Mol Microbiol 56: 934-944, 2005.","DOI":"10.1111\/j.1365-2958.2005.04596.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Hanaoka N, Takano Y, Shibuya K, Fugo H, Uehara Y, Niimi M: Identification of the putative protein phosphatase gene <i>PTC1<\/i> as a virulence-related gene using a silkworm model of <i>Candida albicans<\/i> infection. Eukaryot Cell 7: 1640-1648, 2008.","DOI":"10.1128\/EC.00129-08"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ueno K, Matsumoto Y, Uno J, Sasamoto K, Sekimizu K, Kinjo Y, Chibana H: Intestinal resident yeast <i>Candida glabrata<\/i> requires Cyb2p-mediated lactate assimilation to adapt in mouse intestine. PLoS One 6: e24759, 2011.","DOI":"10.1371\/journal.pone.0024759"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hamamoto H, Urai M, Ishii K, et al: Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane. Nat Chem Biol 11: 127-133, 2015.","DOI":"10.1038\/nchembio.1710"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Paudel A, Panthee S, Urai M, Hamamoto H, Ohwada T, Sekimizu K: Pharmacokinetic parameters explain the therapeutic activity of antimicrobial agents in a silkworm infection model. Sci Rep 8: 1578, 2018.","DOI":"10.1038\/s41598-018-19867-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Nakamura I, Kanasaki R, Yoshikawa K, Furukawa S, Fujie A, Hamamoto H, Sekimizu K: Discovery of a new antifungal agent ASP2397 using a silkworm model of <i>Aspergillus fumigatus<\/i> infection. J Antibiot (Tokyo) 70: 41-44, 2017.","DOI":"10.1038\/ja.2016.106"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Tominaga T, Uchida R, Koyama N, Tomoda H: Anti-<i>Rhizopus<\/i> activity of tanzawaic acids produced by the hot spring-derived fungus <i>Penicillium<\/i> sp. BF-0005. J Antibiot (Tokyo) 71: 626-632, 2018.","DOI":"10.1038\/s41429-018-0049-8"},{"key":"22","unstructured":"22) Clinical and Laboratory Standards Institute: Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. 3rd ed. CLSI standard M38, 2017."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kaito C, Akimitsu N, Watanabe H, Sekimizu K: Silkworm larvae as an animal model of bacterial infection pathogenic to humans. Microb Pathog 32: 183-190, 2002.","DOI":"10.1006\/mpat.2002.0494"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Ishii M, Matsumoto Y, Yamada T, Abe S, Sekimizu K: An invertebrate infection model for evaluating anti-fungal agents against dermatophytosis. Sci Rep 7: 12289, 2017.","DOI":"10.1038\/s41598-017-12523-z"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Ibrahim AS, Gebremariam T, Lin L, Luo G, Husseiny MI, Skory CD, Fu Y, French SW, Edwards JE Jr, Spellberg B: The high affinity iron permease is a key virulence factor required for <i>Rhizopus oryzae<\/i> pathogenesis. Mol Microbiol 77: 587-604, 2010.","DOI":"10.1111\/j.1365-2958.2010.07234.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Liu M, Lin L, Gebremariam T, Luo G, Skory CD, French SW, Chou TF, Edwards JE Jr, Ibrahim AS: Fob1 and Fob2 proteins are virulence determinants of <i>Rhizopus oryzae<\/i> via facilitating iron uptake from ferrioxamine. PLoS Pathog 11: e1004842, 2015.","DOI":"10.1371\/journal.ppat.1004842"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Espinel-Ingroff A, Chakrabarti A, Chowdhary A, et al: Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales. Antimicrob Agents Chemother 59: 1745-1750, 2015.","DOI":"10.1128\/AAC.04435-14"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Shirazi F, Pontikos MA, Walsh TJ, Albert N, Lewis RE, Kontoyiannis DP: Hyperthermia sensitizes <i>Rhizopus oryzae<\/i> to posaconazole and itraconazole action through apoptosis. Antimicrob Agents Chemother 57: 4360-4368, 2013.","DOI":"10.1128\/AAC.00571-13"}],"container-title":["Medical Mycology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/62\/3\/62_21-00004\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T08:56:09Z","timestamp":1673168169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/62\/3\/62_21-00004\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.21-00004","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"21-00004"}}